Sesen Bio
As of the edition of 20 October 2026, Sesen Bio runs 2 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
Sesen Bio was merged in 2023; successor Carisma Therapeutics Inc.
- Sesen Bio, Inc.: merged in 2023; successor Carisma Therapeutics Inc
Drugs by status
| Status | Count |
|---|---|
| Stopped | 1 |
| Status not established | 1 |
| Total | 2 |
Where its trials are
- Cancer: 2 trials led
- Pregnancy and women's health: 1 trials led
- Urinary and reproductive: 1 trials led